BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+13.22%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$25B
AUM Growth
+$25B
(+10%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
3.39%
Top 10 Holdings %
Top 10 Hldgs %
85.68%
Holding
126
New
11
Increased
17
Reduced
63
Closed
6
Top Buys
| 1 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$437M |
| 2 |
Prelude Therapeutics
PRLD
|
$305M |
| 3 |
Kymera Therapeutics
KYMR
|
$63.3M |
| 4 |
Nurix Therapeutics
NRIX
|
$62.5M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$48.2M |
Top Sells
| 1 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$94.5M |
| 2 |
Insmed
INSM
|
$24.2M |
| 3 |
Neurocrine Biosciences
NBIX
|
$22.1M |
| 4 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$21.6M |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$21.1M |
Sector Composition
| 1 | Healthcare | 97.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUTL
76
Autolus Therapeutics
AUTL
$383M
| $5.37M | 0.02% |
461,324
-24,300
| -5% | -$283K |
|
|
RETA
77
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $5.18M | 0.02% |
53,183
-2,800
| -5% | -$273K |
|
78
Replimune Group
REPL
$460M
| $4.76M | 0.02% |
206,586
+201,445
| +3,918% | +$4.64M |
|
79
Crinetics Pharmaceuticals
CRNX
$3.26B
| $4.74M | 0.02% |
302,320
-15,537
| -5% | -$243K |
|
80
InflaRx
IFRX
$117M
| $4.29M | 0.02% |
1,007,559
-50,996
| -5% | -$217K |
|
|
ITOS
81
DELISTED
iTeos Therapeutics
ITOS
| $4.13M | 0.02% |
+167,562
| New | +$4.13M |
|
82
Akero Therapeutics
AKRO
$3.65B
| $4.06M | 0.02% |
+131,788
| New | +$4.06M |
|
83
Legend Biotech
LEGN
$6.64B
| $3.96M | 0.02% |
128,200
-6,800
| -5% | -$210K |
|
84
Denali Therapeutics
DNLI
$2.24B
| $3.56M | 0.01% |
99,400
-5,500
| -5% | -$197K |
|
85
Passage Bio
PASG
$22.7M
| $3.42M | 0.01% |
261,066
-13,934
| -5% | -$183K |
|
86
Ovid Therapeutics
OVID
$94.6M
| $3.39M | 0.01% |
590,761
+132,508
| +29% | +$761K |
|
87
Protara Therapeutics
TARA
$125M
| $3.36M | 0.01% |
199,671
| – | – |
|
|
CHMA
88
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $3.19M | 0.01% |
742,133
-204,568
| -22% | -$880K |
|
|
INZY
89
DELISTED
Inozyme Pharma
INZY
| $3.12M | 0.01% |
+118,500
| New | +$3.12M |
|
|
XLRN
90
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.89M | 0.01% |
25,640
-1,360
| -5% | -$153K |
|
91
Alector
ALEC
$282M
| $2.8M | 0.01% |
265,600
-14,400
| -5% | -$152K |
|
92
Kezar Life Sciences
KZR
$28.5M
| $2.78M | 0.01% |
574,958
-25,042
| -4% | -$121K |
|
|
CNST
93
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $2.7M | 0.01% |
133,333
| – | – |
|
|
GMDA
94
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $2.63M | 0.01% |
633,324
-33,342
| -5% | -$138K |
|
|
TCRR
95
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $2.49M | 0.01% |
+122,532
| New | +$2.49M |
|
96
Intellia Therapeutics
NTLA
$1.26B
| $2.43M | 0.01% |
122,238
-6,300
| -5% | -$125K |
|
97
Viking Therapeutics
VKTX
$3.02B
| $2.35M | 0.01% |
404,200
-20,800
| -5% | -$121K |
|
|
DRNA
98
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.04M | 0.01% |
113,135
-6,200
| -5% | -$112K |
|
99
Arcus Biosciences
RCUS
$1.24B
| $1.98M | 0.01% |
115,425
-6,109
| -5% | -$105K |
|
|
NGM
100
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $1.88M | 0.01% |
118,100
-6,300
| -5% | -$100K |
|